Up And Down The Ladder… Job Changes
Make a commentBy Ed Silverman // November 13th, 2009 // 8:05 am
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone?
And here is something that may become a regular feature. Send us a photo and we will spotlight a different person each week. This time around, we note that Irwin Lerner, a former chief executive officer of Roche’s U.S. pharma biz and most recently interim ceo at Medarex, will be among three inductees into the Medical Advertising Hall of Fame for 2010.
ImmunoGen named director Stephen McCluski as chairman;
Iris International hired Lawrence Blecka as vp of R&D;
UCB New Medicines hired Ismail Kola as president;
PureTech Ventures added John LaMattina as senior partner;
PharmaNet appointed Jeff Trotter as exec vp, phase IV development;
Kendle Consulting named Michael Sprafka vp;
TBWA Worldwide named Gary Wenzel as president of TBWA\WorldHealth;
Mission Pharmacal hired Terrell Herring as president of its pharma division;
RXi Pharmaceutical hired Noah Beerman as ceo and president;
NeurogesX appointed Tim Arendt as vp sales;
NeurogesX hired Amy Cavers as senior director of marketing;
NeurogesX named Linda Schook director of commercial operations;
IFPMA appointed Eduardo Pisnani as director general;
Althea Technologies tapped Jim Matsuura as director of formulation development;
INC Research named Wayne Whittingham vp regulatory affairs and strategic drug development.
Ladder thx to Flickr Creative Commons Robert CB and Irwin comes from nj.com
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Althea Technologies, IFPMA, Immunogen, INC Research, Iris International, Irwin Lerner, Kendle Consulting, Mission Pharmacal, NeurogesX, PharmaNet, PureTech Ventures, RXi Pharmaceutical, TBWA Worldwide, UCB New Medicines